Skip to main content
Erschienen in: Pathology & Oncology Research 2/2019

01.11.2018 | Original Article

CD44 Variant 6 Expression and Tumor Budding in the Medullary Invasion Front of Mandibular Gingival Squamous Cell Carcinoma Are Predictive Factors for Cervical Lymph Node Metastasis

verfasst von: Kohei Okuyama, Hiromasa Fukushima, Tomofumi Naruse, Souichi Yanamoto, Hiroki Tsuchihashi, Masahiro Umeda

Erschienen in: Pathology & Oncology Research | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Oral squamous cell carcinoma (OSCC) with invasion into the mandibular medullary space has been reported to be a predictive factor for cervical lymph node metastasis (CLNM). As CLNM has been associated with the stemness of cancer cells, we aimed to evaluate the relationship between clinical characteristics and immunohistochemical findings on the invasion front of the medullary invasive OSCC and CLNM. The medical records of 25 patients with the mandibular medullary invasive OSCC who were performed mandibulectomy and neck dissection in our department from 2010 to 2016 were examined. Serial sections were stained with antibodies against CD44 variant 6 (CD44v6) to examine cancer stemness and to evaluate the number of tumor buds in the medullary invasion front of the mandibular invasive OSCC. Categorical data were analyzed by Fisher’s exact test. The expression of CD44v6 and the number of tumor buds between the groups with and without pathological CLNM (CLNM+ and CLNM-, respectively) were analyzed using the Mann-Whitney U test. Of the 25 patients, 11 patients were CLNM+. Of the several measured variables, histologic differentiation of the mandibular invasive OSCC was a significant factor for CLNM+. CD44v6 expression and tumor bud formation in the medullary invasion front of the mandibular invasive OSCC were significantly higher in the CLNM+ group, suggests that both CD44v6 and tumor budding in the medullary invasion front are predictive factors for CLNM.
Literatur
1.
Zurück zum Zitat Rautava J, Luukkaa M, Heikinheimo K, Alin J, Grenman R, Happonen RP (2007) Squamous cell carcinomas arising from different types of oral epithelia differ in their tumor and patient characteristics and survival. Oral Oncol 43:911–919CrossRefPubMed Rautava J, Luukkaa M, Heikinheimo K, Alin J, Grenman R, Happonen RP (2007) Squamous cell carcinomas arising from different types of oral epithelia differ in their tumor and patient characteristics and survival. Oral Oncol 43:911–919CrossRefPubMed
2.
Zurück zum Zitat Shingaki S, Nomura T, Takada M, Kobayashi T, Suzuki I, Nakajima T (2002) Squamous cell carcinomas of the mandibular alveolus: analysis of prognostic factors. Oncology 62:17–24CrossRefPubMed Shingaki S, Nomura T, Takada M, Kobayashi T, Suzuki I, Nakajima T (2002) Squamous cell carcinomas of the mandibular alveolus: analysis of prognostic factors. Oncology 62:17–24CrossRefPubMed
3.
Zurück zum Zitat Fitzpatrick SG, Neuman AN, Cohen DM, Bhattacharyya I (2012) The clinical and histologic presentation of gingival squamous cell carcinoma: a study of 519 cases. Oral Surg Oral Med Oral Pathol Oral Radiol 114:509–515CrossRefPubMed Fitzpatrick SG, Neuman AN, Cohen DM, Bhattacharyya I (2012) The clinical and histologic presentation of gingival squamous cell carcinoma: a study of 519 cases. Oral Surg Oral Med Oral Pathol Oral Radiol 114:509–515CrossRefPubMed
4.
Zurück zum Zitat Soo KC, Spiro RH, King W, Harvey W, Strong EW (1988) Squamous carcinoma of the gums. Am J Surg 156:281–285CrossRefPubMed Soo KC, Spiro RH, King W, Harvey W, Strong EW (1988) Squamous carcinoma of the gums. Am J Surg 156:281–285CrossRefPubMed
5.
Zurück zum Zitat Overholt SM, Eicher SA, Wolf P, Weber RS (1996) Prognostic factors affecting outcome in lower gingival carcinoma. Laryngoscope 106:1335–1339CrossRefPubMed Overholt SM, Eicher SA, Wolf P, Weber RS (1996) Prognostic factors affecting outcome in lower gingival carcinoma. Laryngoscope 106:1335–1339CrossRefPubMed
6.
Zurück zum Zitat Seoane J, Varela-Centelles PI, Walsh TF, Lopez-Cedrun JL, Vazquez I (2006) Gingival squamous cell carcinoma: diagnostic delay or rapid invasion? J Periodontol 77:1229–1233CrossRefPubMed Seoane J, Varela-Centelles PI, Walsh TF, Lopez-Cedrun JL, Vazquez I (2006) Gingival squamous cell carcinoma: diagnostic delay or rapid invasion? J Periodontol 77:1229–1233CrossRefPubMed
7.
Zurück zum Zitat Gomez D, Faucher A, Picot V, Siberchicot F, Renaud-Salis JL, Bussières E, Pinsolle J (2000) Outcome of squamous cell carcinoma of the gingiva: a follow-up study of 83 cases. J Craniomaxillofac Surg 28:331–335CrossRefPubMed Gomez D, Faucher A, Picot V, Siberchicot F, Renaud-Salis JL, Bussières E, Pinsolle J (2000) Outcome of squamous cell carcinoma of the gingiva: a follow-up study of 83 cases. J Craniomaxillofac Surg 28:331–335CrossRefPubMed
8.
Zurück zum Zitat Ebrahimi A, Murali R, Gao K, Elliott MS, Clark JR (2011) The prognostic and staging implications of bone invasion in oral squamous cell carcinoma. Cancer 117:4460–4467CrossRefPubMed Ebrahimi A, Murali R, Gao K, Elliott MS, Clark JR (2011) The prognostic and staging implications of bone invasion in oral squamous cell carcinoma. Cancer 117:4460–4467CrossRefPubMed
9.
Zurück zum Zitat Lubek J, El-Hakim M, Salama AR et al (2011) Gingival carcinoma: retrospective analysis of 72 patients and indications for elective neck dissection. Br J Oral Maxillofac Surg 49:182–185CrossRefPubMed Lubek J, El-Hakim M, Salama AR et al (2011) Gingival carcinoma: retrospective analysis of 72 patients and indications for elective neck dissection. Br J Oral Maxillofac Surg 49:182–185CrossRefPubMed
10.
Zurück zum Zitat Niu LX, Feng ZE, Wang DC, Zhang JY, Sun ZP, Guo CB (2017) Prognostic factors in mandibular gingival squamous cell carcinoma: a 10-year retrospective study. Int J Oral Maxillofac Surg 46:137–143CrossRefPubMed Niu LX, Feng ZE, Wang DC, Zhang JY, Sun ZP, Guo CB (2017) Prognostic factors in mandibular gingival squamous cell carcinoma: a 10-year retrospective study. Int J Oral Maxillofac Surg 46:137–143CrossRefPubMed
11.
Zurück zum Zitat Ogura I, Kurabayashi T, Amagasa T, Okada N, Sasaki T (2002) Mandibular bone invasion by gingival carcinoma on dental CT images as an indicator of cervical lymph node metastasis. Dentomaxillofac Radiol 31:339–343CrossRefPubMed Ogura I, Kurabayashi T, Amagasa T, Okada N, Sasaki T (2002) Mandibular bone invasion by gingival carcinoma on dental CT images as an indicator of cervical lymph node metastasis. Dentomaxillofac Radiol 31:339–343CrossRefPubMed
12.
Zurück zum Zitat Platz H, Fries R, Hudec M et al (1983) The prognostic relevance of various factors at the time of the first admission of the patient. retrospective DOSAC study on carcinoma of the oral cavity J Maxillofac Surg 11:3–12 Platz H, Fries R, Hudec M et al (1983) The prognostic relevance of various factors at the time of the first admission of the patient. retrospective DOSAC study on carcinoma of the oral cavity J Maxillofac Surg 11:3–12
13.
Zurück zum Zitat Okura M, Yanamoto S, Umeda M, Otsuru M, Ota Y, Kurita H, Kamata T, Kirita T, Yamakawa N, Yamashita T, Ueda M, Komori T, Hasegawa T, Aikawa T, Japan Oral Oncology Group (2016) Prognostic and staging implications of mandibular canal invasion in lower gingival squamous cell carcinoma. Cancer Med 5:3378–3385CrossRefPubMedPubMedCentral Okura M, Yanamoto S, Umeda M, Otsuru M, Ota Y, Kurita H, Kamata T, Kirita T, Yamakawa N, Yamashita T, Ueda M, Komori T, Hasegawa T, Aikawa T, Japan Oral Oncology Group (2016) Prognostic and staging implications of mandibular canal invasion in lower gingival squamous cell carcinoma. Cancer Med 5:3378–3385CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Matsushita Y, Yanamoto S, Yamada S, Mori H, Adachi M, Takahashi H, Naruse T, Ikeda H, Shiraishi T, Minamikawa T, Shibuya Y, Komori T, Asahina I, Umeda M (2015) Correlation between degree of mandibular bone invasion and prognosis in carcinoma of the mandibular gingiva: soft tissue classification based on UICC classification. J Oral Maxillofac Surg Med Pathol 27:631–636CrossRef Matsushita Y, Yanamoto S, Yamada S, Mori H, Adachi M, Takahashi H, Naruse T, Ikeda H, Shiraishi T, Minamikawa T, Shibuya Y, Komori T, Asahina I, Umeda M (2015) Correlation between degree of mandibular bone invasion and prognosis in carcinoma of the mandibular gingiva: soft tissue classification based on UICC classification. J Oral Maxillofac Surg Med Pathol 27:631–636CrossRef
16.
Zurück zum Zitat Orian-Rousseau V (2010) CD44, a therapeutic target for metastasizing tumours. Eur J Cancer 46:1271–1277CrossRefPubMed Orian-Rousseau V (2010) CD44, a therapeutic target for metastasizing tumours. Eur J Cancer 46:1271–1277CrossRefPubMed
17.
Zurück zum Zitat Monteiro LS, Delgado ML, Ricardo S, do Amaral B, Salazar F, Pacheco JJ, Lopes CA, Bousbaa H, Warnakulasuryia S (2016) Prognostic significance of CD44v6, p63, podoplanin and MMP-9 in oral squamous cell carcinomas. Oral Dis 22:303–312CrossRefPubMed Monteiro LS, Delgado ML, Ricardo S, do Amaral B, Salazar F, Pacheco JJ, Lopes CA, Bousbaa H, Warnakulasuryia S (2016) Prognostic significance of CD44v6, p63, podoplanin and MMP-9 in oral squamous cell carcinomas. Oral Dis 22:303–312CrossRefPubMed
18.
Zurück zum Zitat Yanamoto S, Yamada S, Takahashi H et al (2014) Expression of the cancer stem cell markers CD44v6 and ABCG2 in tongue cancer: effect of neoadjuvant chemotherapy on local recurrence. Int J Oncol 44:1153–1162CrossRefPubMed Yanamoto S, Yamada S, Takahashi H et al (2014) Expression of the cancer stem cell markers CD44v6 and ABCG2 in tongue cancer: effect of neoadjuvant chemotherapy on local recurrence. Int J Oncol 44:1153–1162CrossRefPubMed
19.
Zurück zum Zitat Wang C, Huang H, Wang A et al (2011) Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinoma. J Oral Pathol Med 40:545–551CrossRefPubMedPubMedCentral Wang C, Huang H, Wang A et al (2011) Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinoma. J Oral Pathol Med 40:545–551CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Shimizu S, Miyazaki A, Sonoda T, Koike K, Ogi K, Kobayashi JI, Kaneko T, Igarashi T, Ueda M, Dehari H, Miyakawa A, Hasegawa T, Hiratsuka H (2018) Tumor budding is an independent prognostic marker in early stage oral squamous cell carcinoma: with special reference to the mode of invasion and worst pattern of invasion. PLoS One 13:e0195451CrossRefPubMedPubMedCentral Shimizu S, Miyazaki A, Sonoda T, Koike K, Ogi K, Kobayashi JI, Kaneko T, Igarashi T, Ueda M, Dehari H, Miyakawa A, Hasegawa T, Hiratsuka H (2018) Tumor budding is an independent prognostic marker in early stage oral squamous cell carcinoma: with special reference to the mode of invasion and worst pattern of invasion. PLoS One 13:e0195451CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Hong KO Oh KY1, shin WJ et al. tumor budding is associated with poor prognosis of oral squamous cell carcinoma and histologically represents an epithelial-mesenchymal transition process. Hum Pathol in Press Hong KO Oh KY1, shin WJ et al. tumor budding is associated with poor prognosis of oral squamous cell carcinoma and histologically represents an epithelial-mesenchymal transition process. Hum Pathol in Press
22.
Zurück zum Zitat Mitrovic B, Schaeffer DF, Riddell RH, Kirsch R (2012) Tumor budding in colorectal carcinoma: time to take notice. Modern Pathol 25:1315–1325CrossRef Mitrovic B, Schaeffer DF, Riddell RH, Kirsch R (2012) Tumor budding in colorectal carcinoma: time to take notice. Modern Pathol 25:1315–1325CrossRef
23.
Zurück zum Zitat Pinborg JJ, Reichart PA, Smith CJ et al (1997) World Health Organization histological typing of cancer and precancer of the oral mucosa, 2nd edn, Springer Pinborg JJ, Reichart PA, Smith CJ et al (1997) World Health Organization histological typing of cancer and precancer of the oral mucosa, 2nd edn, Springer
24.
Zurück zum Zitat Sloan P, Gale N, Hunter K et al (2017) Malignant surface epithelial tumours: squamous cell carcinoma. In: el-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (eds) WHO classification of tumours of the head and neck, 4th edn. IARC Press, Lyon Sloan P, Gale N, Hunter K et al (2017) Malignant surface epithelial tumours: squamous cell carcinoma. In: el-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (eds) WHO classification of tumours of the head and neck, 4th edn. IARC Press, Lyon
25.
Zurück zum Zitat Okuyama K, Michi Y, Mizutani M, Yamashiro M, Kaida A, Harada K (2016) Clinical study on mandibular fracture after marginal resection of the mandible. Oral Surg Oral Med Oral Pathol Oral Radiol 121:461–467CrossRefPubMed Okuyama K, Michi Y, Mizutani M, Yamashiro M, Kaida A, Harada K (2016) Clinical study on mandibular fracture after marginal resection of the mandible. Oral Surg Oral Med Oral Pathol Oral Radiol 121:461–467CrossRefPubMed
26.
Zurück zum Zitat Fonseca I, Pereira T, Rosa-Santos J, Soares J (2001) Expression of CD44 isoforms in squamous cell carcinoma of the border of the tongue: a correlation with histological grade, pattern of stromal invasion, and cell differentiation. J Surg Oncol 76:115–120CrossRefPubMed Fonseca I, Pereira T, Rosa-Santos J, Soares J (2001) Expression of CD44 isoforms in squamous cell carcinoma of the border of the tongue: a correlation with histological grade, pattern of stromal invasion, and cell differentiation. J Surg Oncol 76:115–120CrossRefPubMed
27.
Zurück zum Zitat Masaki T, Goto A, Sugiyama M, Matsuoka H, Abe N, Sakamoto A, Atomi Y (2001) Possible contribution of CD44 variant 6 and nuclear beta-catenin expression to the formation of budding tumor cells in patients with T1 colorectal carcinoma. Cancer 92:2539–2546CrossRefPubMed Masaki T, Goto A, Sugiyama M, Matsuoka H, Abe N, Sakamoto A, Atomi Y (2001) Possible contribution of CD44 variant 6 and nuclear beta-catenin expression to the formation of budding tumor cells in patients with T1 colorectal carcinoma. Cancer 92:2539–2546CrossRefPubMed
28.
Zurück zum Zitat Seki M, Sano T, Yokoo S, Oyama T (2016) Histologic assessment of tumor budding in preoperative biopsies to predict nodal metastasis in squamous cell carcinoma of the tongue and floor of the mouth. Head Neck 38(Suppl 1):E1582–E1590CrossRefPubMed Seki M, Sano T, Yokoo S, Oyama T (2016) Histologic assessment of tumor budding in preoperative biopsies to predict nodal metastasis in squamous cell carcinoma of the tongue and floor of the mouth. Head Neck 38(Suppl 1):E1582–E1590CrossRefPubMed
29.
Zurück zum Zitat Nomura T, Shibahara T, Cui NH, Noma H (2005) Patterns of mandibular invasion by gingival squamous cell carcinoma. J Oral Maxillofac Surg 63:1489–1493CrossRefPubMed Nomura T, Shibahara T, Cui NH, Noma H (2005) Patterns of mandibular invasion by gingival squamous cell carcinoma. J Oral Maxillofac Surg 63:1489–1493CrossRefPubMed
Metadaten
Titel
CD44 Variant 6 Expression and Tumor Budding in the Medullary Invasion Front of Mandibular Gingival Squamous Cell Carcinoma Are Predictive Factors for Cervical Lymph Node Metastasis
verfasst von
Kohei Okuyama
Hiromasa Fukushima
Tomofumi Naruse
Souichi Yanamoto
Hiroki Tsuchihashi
Masahiro Umeda
Publikationsdatum
01.11.2018
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 2/2019
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-018-0529-y

Weitere Artikel der Ausgabe 2/2019

Pathology & Oncology Research 2/2019 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.